Haw Par Corporation Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HAWPY research report →
About the company
Haw Par Corporation Limited, through its numerous subsidiaries, engages in the creation, distribution, and sale of healthcare products across Singapore, the ASEAN region, other Asian nations, and internationally. Its business is structured into three main divisions: Healthcare, Investments, and a general "Others" category. The Healthcare segment's primary focus is on manufacturing and supplying topical analgesic remedies, notably the prominent Tiger Balm and Kwan Loong brands.
- CEO
- Ee Lim Wee
- IPO
- 2013
- Employees
- 595
- HQ
- Singapore, SG
Price Chart
- Market Cap
- $2.96B
- P/E
- 13.27
- P/S
- 15.33
- P/B
- 0.82
- EV/EBITDA
- 37.84
- Div Yield
- 2.51%
- Gross Margin
- 55.99%
- Op Margin
- 29.17%
- Net Margin
- 115.43%
- ROE
- 6.34%
- ROIC
- 1.46%
- Revenue
- $226.29M · -7.57%
- Net Income
- $261.22M · 14.43%
- EPS
- $4.72 · 14.56%
- Op Income
- $66.02M
- FCF YoY
- 426.27%
- 52W High
- $54.44
- 52W Low
- $28.64
- 50D MA
- $53.50
- 200D MA
- $51.73
- Beta
- 0.16
- Avg Volume
- 12.74
Get TickerSpark's AI analysis on HAWPY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HAWPY coverage
Recent articles, reports, and earnings notes.
No research on HAWPY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HAWPY report →Similar companies
Peers in the same neighborhood.